CY1108332T1 - Φαρμακο για τη θεραπεια μυκητιακων λοιμωξεων, ειδικοτερα της ασπεργιλλωσης - Google Patents

Φαρμακο για τη θεραπεια μυκητιακων λοιμωξεων, ειδικοτερα της ασπεργιλλωσης

Info

Publication number
CY1108332T1
CY1108332T1 CY20081100978T CY081100978T CY1108332T1 CY 1108332 T1 CY1108332 T1 CY 1108332T1 CY 20081100978 T CY20081100978 T CY 20081100978T CY 081100978 T CY081100978 T CY 081100978T CY 1108332 T1 CY1108332 T1 CY 1108332T1
Authority
CY
Cyprus
Prior art keywords
infections
treatment
medicine
functional
fumingatus
Prior art date
Application number
CY20081100978T
Other languages
English (en)
Inventor
Giovanni Salvatori
Paolo Carminati
Luigina Romani
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of CY1108332T1 publication Critical patent/CY1108332T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Περιγράφεται ένας συνδυασμός πεντραξίνης PTX3 με αντιμηκητιακά για τη θεραπεία μυκητιακών λοιμώξεων και ειδικότερα για λοιμώξεις που προκαλούνται από Aspergillus fumingatus.
CY20081100978T 2004-05-07 2008-09-11 Φαρμακο για τη θεραπεια μυκητιακων λοιμωξεων, ειδικοτερα της ασπεργιλλωσης CY1108332T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000223A ITRM20040223A1 (it) 2004-05-07 2004-05-07 Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.
EP05742910A EP1750744B1 (en) 2004-05-07 2005-04-28 Medicament for the treatment of fungal infections, particularly aspergillosis

Publications (1)

Publication Number Publication Date
CY1108332T1 true CY1108332T1 (el) 2014-02-12

Family

ID=34968212

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100978T CY1108332T1 (el) 2004-05-07 2008-09-11 Φαρμακο για τη θεραπεια μυκητιακων λοιμωξεων, ειδικοτερα της ασπεργιλλωσης

Country Status (25)

Country Link
US (2) US8778389B2 (el)
EP (1) EP1750744B1 (el)
JP (1) JP5574565B2 (el)
KR (1) KR101192611B1 (el)
CN (1) CN1950104B (el)
AR (1) AR048775A1 (el)
AT (1) ATE397937T1 (el)
AU (1) AU2005239913B2 (el)
BR (1) BRPI0510718A (el)
CA (1) CA2563400C (el)
CY (1) CY1108332T1 (el)
DE (1) DE602005007485D1 (el)
DK (1) DK1750744T3 (el)
ES (1) ES2306145T3 (el)
HK (1) HK1103961A1 (el)
HR (1) HRP20080413T3 (el)
IT (1) ITRM20040223A1 (el)
ME (1) ME02743B (el)
MX (1) MXPA06012889A (el)
PL (1) PL1750744T3 (el)
PT (1) PT1750744E (el)
RS (1) RS50591B (el)
SI (1) SI1750744T1 (el)
TW (1) TWI393569B (el)
WO (1) WO2005107791A1 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040489A1 (it) * 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
ITMI20062448A1 (it) * 2006-12-19 2008-06-20 Univ Degli Studi Modena E Reggio Emilia Metodo per la diagnosi e/o il monitoraggio dell¿ aspergillosi invasiva
US8838152B2 (en) 2007-11-30 2014-09-16 Microsoft Corporation Modifying mobile device operation using proximity relationships
CN101280326B (zh) * 2008-05-14 2011-07-06 中国科学院微生物研究所 一种抑制烟曲霉活性的化合物制备方法及其应用
WO2013191280A1 (ja) * 2012-06-22 2013-12-27 国立大学法人 東京大学 全身性炎症反応症候群の治療又は予防剤
WO2019229241A1 (en) * 2018-06-01 2019-12-05 B.R.A.H.M.S Gmbh Biomarkers for the diagnosis of invasive fungal infections
EP3669885A1 (en) * 2018-12-20 2020-06-24 Humanitas Mirasole S.p.A. Use of sap for the treatment of eurotiomycetes fungi infections
CN113952401B (zh) * 2021-12-15 2022-10-25 河北农业大学 一种用于防治畜禽曲霉菌感染的中药及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
AU598958B2 (en) * 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
JP2001183375A (ja) 1999-12-27 2001-07-06 Tosoh Corp 酵素標識抗体
US20050187161A1 (en) * 2003-09-12 2005-08-25 Board Of Regents, The University Of Texas System Biopanning as an approach to study the pathogenesis of and produce novel treatment modalities for invasive Aspergillosis
WO2005091754A2 (en) * 2004-03-29 2005-10-06 University Of Mississippi Novel cyclopentenedione antifungal compounds and methods for their use
ITRM20040489A1 (it) 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
EP1832295A1 (en) 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
WO2007128647A1 (en) 2006-05-02 2007-11-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. USE OF THYMOSIN α1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION

Also Published As

Publication number Publication date
TW200602075A (en) 2006-01-16
CA2563400A1 (en) 2005-11-17
JP5574565B2 (ja) 2014-08-20
CA2563400C (en) 2013-07-30
MXPA06012889A (es) 2007-02-15
AR048775A1 (es) 2006-05-24
KR101192611B1 (ko) 2012-10-18
US8778389B2 (en) 2014-07-15
PL1750744T3 (pl) 2008-11-28
HK1103961A1 (en) 2008-01-04
RS50591B (sr) 2010-05-07
CN1950104A (zh) 2007-04-18
US20080026997A1 (en) 2008-01-31
AU2005239913B2 (en) 2011-08-18
CN1950104B (zh) 2010-11-10
EP1750744A1 (en) 2007-02-14
ME02743B (me) 2010-05-07
US20140296135A1 (en) 2014-10-02
KR20070007375A (ko) 2007-01-15
SI1750744T1 (sl) 2008-10-31
EP1750744B1 (en) 2008-06-11
JP2007536380A (ja) 2007-12-13
BRPI0510718A (pt) 2007-11-20
DE602005007485D1 (de) 2008-07-24
DK1750744T3 (da) 2008-09-29
ITRM20040223A1 (it) 2004-08-07
WO2005107791A1 (en) 2005-11-17
AU2005239913A1 (en) 2005-11-17
HRP20080413T3 (en) 2008-10-31
TWI393569B (zh) 2013-04-21
ATE397937T1 (de) 2008-07-15
PT1750744E (pt) 2008-08-14
ES2306145T3 (es) 2008-11-01

Similar Documents

Publication Publication Date Title
CY1108332T1 (el) Φαρμακο για τη θεραπεια μυκητιακων λοιμωξεων, ειδικοτερα της ασπεργιλλωσης
IL258702B (en) Pump system for use in organ treatment systems
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
CY1118760T1 (el) Τροποποιημενα αντισωματα εναντι il-23
CY1113770T1 (el) Κυκλικα αντι-μικροβιακα πεπτιδια
CY1112946T1 (el) 4-υδροξυβενζομορφανια
CL2008001498A1 (es) Uso de un anticuerpo contra el factor d en la prevencion o tratamiento de una condicion ocular asociada al complemento.
DE602005022430D1 (de) Medizinproduktsysteme
AR052165A1 (es) Tratamiento de hepatitis c en la poblacion asiatica
AU303119S (en) Package
GB2477906A (en) Discreet packaging for personal products
DE602004015487D1 (de) Programmiergerät für medizinisches gerät mit infrarot-kommunikation
DK1713438T3 (da) Medicinsk sæbe
DK1869185T3 (da) Konjugat med P21-protein til kræftbehandling
ATE382778T1 (de) Pumpenkombination
BRPI0519348A2 (pt) 5-(2,2-dimetil-ciclopropil)-3metil-pen-2-enenitrila como fragrancia e flavorizante
CR11735A (es) Asociacion de la dronedarona con al menos un diuretico, su aplicacion en terapeutica
RS51900B (en) DEGLIKOZILOVANI AND DIGIALIDOVAN DUGI PENTRAKSIN PTX3
NL1027109A1 (nl) Verbinding en gebruik bij behandeling.
BRPI0812026A2 (pt) mutantes de vegf-d e seu uso
TR200302193T4 (tr) Kombinasyon kemoterapisi.
NO20071330L (no) Enzyminhibitor i leukemi
AR057746A1 (es) Peg-ifn alfa y ribavirina para el tratamiento del virus de hepatitis b
DE602005023138D1 (de) Anti-cea scfv-beta-lactamase konstrukte (cab moleküle) in adept
UA3479U (uk) Наперсток